Incidence of dementia · cognitively healthy people in mid and late life
1 finding from 1 review
Cognitive function · cognitively healthy people in mid and late life
2 findings from 1 review
Incidence of probable dementia or MCI · cognitively healthy people in mid and late life
1 finding from 1 review
Cognitive function · cognitively healthy people in mid and late life
1 finding from 1 review
Incidence of dementia or MCI · cognitively healthy people in mid and late life
1 finding from 1 review
Cognitive function · cognitively healthy people in mid and late life
2 findings from 1 review
Incidence of MCI or all‐cause dementia ‐ not measured · cognitively healthy people in mid and late life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of dementia or MCI · cognitively healthy people in mid and late life
B vitamins showed no clear difference in incidence of MCI or dementia > 2 to 5 years of supplementation compared with placebo (moderate certainty).
1 finding from 1 review
Change in apathy · Apathy in people with mild‐to‐moderate Alzheimer's disease
2 findings from 1 review
Change in apathy · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Adverse Events ‐ reported, but not analyzed in this review · Apathy in people with mild‐to‐moderate Alzheimer's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in NPS ‐ not investigated · Apathy in people with mild‐to‐moderate Alzheimer's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in cognition ‐ not investigated · Apathy in people with mild‐to‐moderate Alzheimer's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in functional performance · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Change in global disease severity ‐ not investigated · Apathy in people with mild‐to‐moderate Alzheimer's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dropouts ‐ reported, but not analyzed in this review · Apathy in people with mild‐to‐moderate Alzheimer's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · Apathy in people with mild‐to‐moderate Alzheimer's disease
Methylphenidate showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Change in NPS · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Change in cognition · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Change in functional performance · Apathy in people with mild‐to‐moderate Alzheimer's disease
2 findings from 1 review